Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Shockwave Medical Inc. gross profit margin ratio improved from 2021 to 2022 and from 2022 to 2023. |
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Shockwave Medical Inc. operating profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Shockwave Medical Inc. net profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Shockwave Medical Inc. ROE improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
ROA | A profitability ratio calculated as net income divided by total assets. | Shockwave Medical Inc. ROA improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023 not reaching 2021 level. |
Gross Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Gross profit | 634,842) | 424,737) | 195,708) | 46,798) | 25,768) | |
Revenue | 730,230) | 489,733) | 237,146) | 67,789) | 42,927) | |
Profitability Ratio | ||||||
Gross profit margin1 | 86.94% | 86.73% | 82.53% | 69.03% | 60.03% | |
Benchmarks | ||||||
Gross Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 50.28% | 51.54% | 52.21% | 50.49% | 52.46% | |
Cigna Group | 12.37% | 12.44% | 12.41% | 14.43% | 15.57% | |
CVS Health Corp. | 14.94% | 16.62% | 17.48% | 18.01% | 17.41% | |
Elevance Health Inc. | 16.79% | 16.79% | 17.09% | 19.71% | 18.77% | |
Intuitive Surgical Inc. | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | |
Medtronic PLC | 65.67% | 67.98% | 65.19% | 67.41% | 70.04% | |
UnitedHealth Group Inc. | 23.64% | 24.09% | 23.60% | 25.62% | 23.19% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenue
= 100 × 634,842 ÷ 730,230 = 86.94%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Shockwave Medical Inc. gross profit margin ratio improved from 2021 to 2022 and from 2022 to 2023. |
Operating Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Income (loss) from operations | 159,093) | 124,134) | (871) | (65,663) | (51,839) | |
Revenue | 730,230) | 489,733) | 237,146) | 67,789) | 42,927) | |
Profitability Ratio | ||||||
Operating profit margin1 | 21.79% | 25.35% | -0.37% | -96.86% | -120.76% | |
Benchmarks | ||||||
Operating Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 16.15% | 19.16% | 19.56% | 15.48% | 14.21% | |
Cigna Group | 4.40% | 4.69% | 4.60% | 5.12% | 5.31% | |
CVS Health Corp. | 3.85% | 2.41% | 4.54% | 5.19% | 4.69% | |
Elevance Health Inc. | 4.47% | 4.94% | 5.15% | 4.97% | 5.49% | |
Humana Inc. | 3.81% | 4.11% | 3.80% | 6.56% | 4.96% | |
Intuitive Surgical Inc. | 24.80% | 25.35% | 31.89% | 24.09% | 30.69% | |
Medtronic PLC | 17.56% | 18.15% | 14.89% | 16.57% | 20.51% | |
UnitedHealth Group Inc. | 8.80% | 8.83% | 8.40% | 8.76% | 8.19% | |
Operating Profit Margin, Sector | ||||||
Health Care Equipment & Services | 6.29% | 6.23% | 6.69% | 7.04% | 6.89% | |
Operating Profit Margin, Industry | ||||||
Health Care | 9.29% | 13.11% | 13.07% | 10.36% | 12.35% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Operating profit margin = 100 × Income (loss) from operations ÷ Revenue
= 100 × 159,093 ÷ 730,230 = 21.79%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Shockwave Medical Inc. operating profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
Net Profit Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Net income (loss) | 147,278) | 215,996) | (9,136) | (65,699) | (51,109) | |
Revenue | 730,230) | 489,733) | 237,146) | 67,789) | 42,927) | |
Profitability Ratio | ||||||
Net profit margin1 | 20.17% | 44.10% | -3.85% | -96.92% | -119.06% | |
Benchmarks | ||||||
Net Profit Margin, Competitors2 | ||||||
Abbott Laboratories | 14.27% | 15.88% | 16.42% | 12.99% | 11.56% | |
Cigna Group | 2.66% | 3.72% | 3.11% | 5.31% | 3.35% | |
CVS Health Corp. | 2.34% | 1.29% | 2.72% | 2.68% | 2.59% | |
Elevance Health Inc. | 3.52% | 3.87% | 4.46% | 3.78% | 4.66% | |
Humana Inc. | 2.36% | 3.03% | 3.54% | 4.43% | 4.20% | |
Intuitive Surgical Inc. | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | |
Medtronic PLC | 12.03% | 15.90% | 11.97% | 16.56% | 15.16% | |
UnitedHealth Group Inc. | 6.09% | 6.25% | 6.06% | 6.03% | 5.76% | |
Net Profit Margin, Sector | ||||||
Health Care Equipment & Services | 4.37% | 4.60% | 4.96% | 5.21% | 4.85% | |
Net Profit Margin, Industry | ||||||
Health Care | 7.95% | 10.17% | 10.82% | 7.69% | 10.13% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Net profit margin = 100 × Net income (loss) ÷ Revenue
= 100 × 147,278 ÷ 730,230 = 20.17%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Shockwave Medical Inc. net profit margin ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
Return on Equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Net income (loss) | 147,278) | 215,996) | (9,136) | (65,699) | (51,109) | |
Stockholders’ equity | 668,677) | 511,316) | 241,830) | 225,654) | 192,653) | |
Profitability Ratio | ||||||
ROE1 | 22.03% | 42.24% | -3.78% | -29.11% | -26.53% | |
Benchmarks | ||||||
ROE, Competitors2 | ||||||
Abbott Laboratories | 14.83% | 18.90% | 19.75% | 13.71% | 11.86% | |
Cigna Group | 11.17% | 14.86% | 11.39% | 16.81% | 11.26% | |
CVS Health Corp. | 10.91% | 5.84% | 10.54% | 10.35% | 10.39% | |
Elevance Health Inc. | 15.23% | 16.59% | 16.93% | 13.77% | 15.15% | |
Humana Inc. | 15.31% | 18.33% | 18.24% | 24.53% | 22.49% | |
Intuitive Surgical Inc. | 13.51% | 11.98% | 14.32% | 10.90% | 16.69% | |
Medtronic PLC | 7.30% | 9.59% | 7.01% | 9.44% | 9.25% | |
UnitedHealth Group Inc. | 25.22% | 25.87% | 24.09% | 23.52% | 24.02% | |
ROE, Sector | ||||||
Health Care Equipment & Services | 15.02% | 15.36% | 15.06% | 15.16% | 14.26% | |
ROE, Industry | ||||||
Health Care | 17.95% | 22.36% | 22.87% | 16.00% | 21.03% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROE = 100 × Net income (loss) ÷ Stockholders’ equity
= 100 × 147,278 ÷ 668,677 = 22.03%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Shockwave Medical Inc. ROE improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023. |
Return on Assets (ROA)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Net income (loss) | 147,278) | 215,996) | (9,136) | (65,699) | (51,109) | |
Total assets | 1,566,563) | 646,089) | 345,682) | 272,042) | 231,938) | |
Profitability Ratio | ||||||
ROA1 | 9.40% | 33.43% | -2.64% | -24.15% | -22.04% | |
Benchmarks | ||||||
ROA, Competitors2 | ||||||
Abbott Laboratories | 7.82% | 9.31% | 9.40% | 6.20% | 5.43% | |
Cigna Group | 3.38% | 4.63% | 3.46% | 5.44% | 3.28% | |
CVS Health Corp. | 3.34% | 1.82% | 3.39% | 3.11% | 2.98% | |
Elevance Health Inc. | 5.50% | 5.86% | 6.26% | 5.28% | 6.21% | |
Humana Inc. | 5.29% | 6.52% | 6.61% | 9.63% | 9.31% | |
Intuitive Surgical Inc. | 11.64% | 10.19% | 12.58% | 9.50% | 14.17% | |
Medtronic PLC | 4.13% | 5.54% | 3.87% | 5.28% | 5.16% | |
UnitedHealth Group Inc. | 8.18% | 8.19% | 8.15% | 7.81% | 7.96% | |
ROA, Sector | ||||||
Health Care Equipment & Services | 5.50% | 5.63% | 5.63% | 5.61% | 5.18% | |
ROA, Industry | ||||||
Health Care | 6.35% | 8.30% | 8.19% | 5.42% | 7.18% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 147,278 ÷ 1,566,563 = 9.40%
2 Click competitor name to see calculations.
Profitability ratio | Description | The company |
---|---|---|
ROA | A profitability ratio calculated as net income divided by total assets. | Shockwave Medical Inc. ROA improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023 not reaching 2021 level. |